Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume → AI Hell Will Break Loose [June 30, 2024] … (From Banyan Hill Publishing) (Ad) Free INDP Stock Alerts $2.63 +0.11 (+4.36%) (As of 06/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Indaptus Therapeutics Short Interest DataCurrent Short Interest16,600 sharesPrevious Short Interest25,800 sharesChange Vs. Previous Month-35.66%Dollar Volume Sold Short$36,686.00Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares8,540,000 sharesFloat Size5,900,000 sharesShort Percent of Float0.28%Today's Trading Volume22,904 sharesAverage Trading Volume35,847 sharesToday's Volume Vs. Average64% Short Selling Indaptus Therapeutics ? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202416,600 shares $36,686.00 -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55,986.00 -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228,430.00 -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224,224.00 +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185,878.00 +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73,700.00 +94.8%0.6%0.5 $2.20 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202417,200 shares $29,928.00 +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23,925.00 -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33,855.00 -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36,080.00 -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44,748.00 -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52,432.00 +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42,020.00 +64.7%0.3%1 $2.20 10/31/202311,600 shares $26,448.00 -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30,720.00 -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38,570.00 -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69,290.00 -9.3%0.4%1 $3.38 8/31/202322,600 shares $64,862.00 -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104,608.00 +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44,919.00 +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31,730.00 -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32,470.00 -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46,452.00 -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43,847.00 -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56,160.00 -51.4%0.5%1 $2.08 4/30/202355,600 shares $145,060.40 +159.8%1.0%2 $2.61 4/15/202321,400 shares $41,730.00 -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43,660.00 -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41,040.00 +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45,150.00 -21.3%0.5%1 $1.75 2/15/202332,800 shares $58,712.00 -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69,207.00 +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61,451.00 -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77,865.00 -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195,000.00 +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30,415.71 -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30,276.75 +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30,378.00 +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27,360.00 -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38,448.00 -21.9%0.4%1.1 $2.16Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… 9/15/202222,800 shares $61,104.00 -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62,496.00 -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105,270.00 -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163,300.00 -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256,410.00 +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134,154.00 -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200,480.00 -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460,713.00 +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67,456.00 -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129,213.00 -14.7%0.8%1 $2.93 4/15/202251,700 shares $177,331.00 -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252,400.00 -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289,971.00 +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313,500.00 +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351,000.00 -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531,934.00 +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547,536.00 +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229,710.00 No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 16,600 shares of INDP short. 0.28% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a drop in short interest in May. As of May 15th, there was short interest totaling 16,600 shares, a drop of 35.7% from the previous total of 25,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 8,540,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 5,900,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 0.28% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Indaptus Therapeutics: Clearside Biomedical, Inc. (0.46%), Verastem, Inc. (3.94%), InflaRx (0.12%), ProPhase Labs, Inc. (1.36%), Eton Pharmaceuticals, Inc. (0.35%), SCYNEXIS, Inc. (2.91%), Assertio Holdings, Inc. (11.28%), Connect Biopharma Holdings Limited (0.10%), Relmada Therapeutics, Inc. (5.20%), PMV Pharmaceuticals, Inc. (6.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CLSD Short Interest Data VSTM Short Interest Data IFRX Short Interest Data PRPH Short Interest Data ETON Short Interest Data SCYX Short Interest Data ASRT Short Interest Data CNTB Short Interest Data RLMD Short Interest Data PMVP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.